CPT1A and pulmonary arterial hypertension: Perhexiline, a recognized CPT1 inhibitor commonly used for heart failure treatment [136], and its fluorinated derivative fluorinated perhexiline derivative 1 (FPER-1), reverse the Warburg effect in PASMCs of PAH by inhibiting CPT1 [84].